Tandem peptides targeting HER2 for delivery of CD44 siRNA into HER2+breast cancer cells in vitro

被引:0
|
作者
Kalogeros, James W.
Miserendino, Audreanna
Alexander-Bryant, Angela
Booth, Brian
机构
基金
美国国家科学基金会;
关键词
D O I
10.1158/1538-7445.AM2023-3979
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3979
引用
收藏
页数:2
相关论文
共 50 条
  • [21] CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
    Boulbes, Delphine R.
    Chauhan, Gaurav B.
    Jin, Quanri
    Bartholomeusz, Chandra
    Esteva, Francisco J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 501 - 513
  • [22] CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
    Delphine R. Boulbes
    Gaurav B. Chauhan
    Quanri Jin
    Chandra Bartholomeusz
    Francisco J. Esteva
    Breast Cancer Research and Treatment, 2015, 151 : 501 - 513
  • [23] HER2-SCFV-PROTAMINE MEDIATION IN DELIVERY OF PLK1 SIRNA TO HER2 OVEREXPRESSED BREAST CANCER
    Song, E.
    Yao, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 51 - 52
  • [24] Genomics of HER2+breast cancer
    Perou, C.
    CANCER RESEARCH, 2022, 82 (04)
  • [25] Targeting trastuzumab-resistant HER2+breast cancer with a HER3-targeting nanoparticle
    Sims, Jessica
    Taguaim, Michael
    Hanson, Chris
    Cui, Xiaojiang
    Medina-Kauwe, Lali K.
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Targeting HER2 in breast cancer: beyond trastuzumab
    EP Winer
    Breast Cancer Research, 13
  • [27] Dual HER2 targeting for early breast cancer
    Johnston, Stephen R. D.
    LANCET ONCOLOGY, 2013, 14 (12): : 1145 - 1146
  • [28] The Evolving Landscape of HER2 Targeting in Breast Cancer
    Moasser, Mark M.
    Krop, Ian E.
    JAMA ONCOLOGY, 2015, 1 (08) : 1154 - 1161
  • [29] Targeting HER2 in breast cancer: beyond trastuzumab
    Winer, F. P.
    BREAST CANCER RESEARCH, 2011, 13
  • [30] Microenvironment mediated mechanisms of resistance to HER2 inhibitors differ between HER2+breast cancer subtypes
    Watson, Spencer
    Gray, Joe
    Korkola, James
    Dane, Mark
    Hesier, Laura
    Chin, Koei
    Mills, Gordon
    CANCER RESEARCH, 2017, 77